Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07083674 · ClinicalTrials.gov registry record · NA
TeamTalk: Improving Inter-professional Communication During Cancer Treatment
A NA study, sponsored by Washington University School of Medicine.
- Not yet
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT07083674: Clinical Trial NA study, sponsored by Washington University School of Medicine.
NCT07083674 is a NA study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07083674, a NA study, has not yet begun recruiting, sponsored by Washington University School of Medicine.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study focuses on improving interprofessional communication during cancer treatment, through an individual and hospital system intervention, to improve provider outcomes, patient care, and, ultimately, survival for children with cancer in low-resource settings.
Primary Outcome
Reliable, published measure of communication quality; measured across 6 domains on a Likert scale; self reported by clinical team members; Will assess change in clinician perspective of communication quality within 6 months
Interventions
- BEHAVIORAL Multi-level communication intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2027-09-23 |
| Est. Completion | 2029-08 |
| Phase | NA |
What is known before NCT07083674 opens enrollment
NCT07083674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Multi-level communication intervention is the first listed.
NCT07083674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07083674 about?
NCT07083674 is a clinical study titled "TeamTalk: Improving Inter-professional Communication During Cancer Treatment". This study focuses on improving interprofessional communication during cancer treatment, through an individual and hospital system intervention, to improve provider outcomes, patient care, and, ultimately, survival for children with cancer in low-resource settings.
What is the current status of trial NCT07083674?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2027-09-23. Estimated completion is 2029-08.
What interventions are being tested in trial NCT07083674?
The interventions under investigation include: Multi-level communication intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07083674?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07083674's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI